{
    "$schema": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/QualificationPlan/v3.3/schemas/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Omeprazole",
            "Path": "../../Omeprazole-Model.json",
            "BuildingBlocks": [],
            "SimulationParameters": []
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "AxesSettings": {
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Concentration (molar)",
                    "Unit": "µmol/l",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (molar)",
                    "Unit": "µmol/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "ComparisonTimeProfile": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (molar)",
                    "Unit": "µmol/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "PKRatioPlots": [
                {
                    "Type": "X",
                    "Dimension": "Age",
                    "Unit": "year(s)",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AllPlots": [
            {
                "Project": "Omeprazole",
                "Simulation": "E.1.Esomeprazole IV 20 mg - 5d QD (Hassan-Alin2000)",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "E.2. Esomeprazole IV 40 mg - 5d QD (Hassan-Alin2000, Wilder-Smith2005)",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "E.4. Esomeprazole IV 80mg(30min)+4mg/h - SD (Rohss2007)",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "E.3. Esomeprazole IV 40mg(30min)+8mg/h - (Rohss2007)",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "E.5. Esomeprazole IV 80mg(30min)+8mg/h - SD (Rohss2007) - pred",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "E.6. Esomeprazole IV 120mg(30min)+8mg/h - SD (Rohss2007)",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "E.7. Esomeprazole IV 120mg(2h)+8mg/h - SD (Rohss2007).",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "E.13 - MD in EM - Esomeprazole PO 15 mg solution (Andersson2000)",
                "SectionReference": "model-verification"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "E.8 - Esomeprazole PO 20 mg oral solution- 5d QD (Hassan-Alin2005).",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "E.9 - Esomeprazole PO 40 mg oral solution- 5d QD (Hassan-Alin2005)",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "E.11 - SD in EM - Esomeprazole PO 40 mg- FDA - same schema as E.9",
                "SectionReference": "model-verification"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "Esomeprazole PO 40 mg capsule - 5d QD (Wilder-Smith2005)- with Fit formulation",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "E.14 - MD in PM (no 2C19CL) - Esomeprazole PO 60 mg solution (Andersson2000)",
                "SectionReference": "model-verification"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "R.3 - R-omeprazole po 15 mg - 7d QD (Andersson2000) - EM",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "R.1 - R-omeprazole po 20 mg - 5d QD (Hassan-Alin2005)",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "R.2 - R-omeprazole po 40 mg - 5d QD (Hassan-Alin2005)",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "R.4 - R-omeprazole po 60 mg - 7d QD (Andersson2000) - PM - CL Fit",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O5. Omeprazole iv 10mg",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O1. Omeprazole iv 10 mg - SD (Regardh1990) - PM",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O4. Omeprazole iv 20 mg - SD",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O2. Omeprazole iv 20 mg - SD in PM (Uno2007)",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O3. Omeprazole iv 40 mg - SD",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O6. Omeprazole iv 80mg",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O9. Omeprazole po 15 mg - oral solution - (Andersson2000) - MD in EM",
                "SectionReference": "model-verification"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O8. Omeprazole po 20 mg - oral solution - SD and MD",
                "SectionReference": "model-verification"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O8. Omeprazole po 20 mg - 5d QD - capsule",
                "SectionReference": "model-verification"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O8. Omeprazole po 20 mg - 5d QD - capsule - PM",
                "SectionReference": "model-verification"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O7. Omeprazole po 40mg - oral solution- SD and MD",
                "SectionReference": "model-verification"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O.1. pop - Omeprazole po 20 mg - DDI without moclobemide - (Cho2002)",
                "SectionReference": "model-verification"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O.1. pop - Omeprazole po 20 mg - DDI without moclobemide - (Cho2002)_pm",
                "SectionReference": "model-verification"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O7. Omeprazole po 40 mg - 5d QD japanese - capsule - EM",
                "SectionReference": "model-verification"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O92. Omeprazole po 60 mg - oral solution - MD in PM",
                "SectionReference": "model-building"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O91. Omeprazole po 80 mg - oral solution - SD",
                "SectionReference": "model-verification"
            },
            {
                "Project": "Omeprazole",
                "Simulation": "O.9. Omeprazole DDI without fluvoxamine",
                "SectionReference": "model-verification"
            }
        ],
        "GOFMergedPlots": [
            {
                "Title": "S-omeprazole concentration in plasma - mean data",
                "SectionReference": "diagnostics-plots",
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure"
                ],
                "PlotTypes": [
                    "predictedVsObserved",
                    "residualsOverTime"
                ],
                "Groups": [
                    {
                        "Caption": "iv administration (model building)",
                        "Symbol": "Cross",
                        "OutputMappings": [
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.1.Esomeprazole IV 20 mg - 5d QD (Hassan-Alin2000)",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hassan-Alin2000.Esomeprazole.20mg.IV_30min_infusion",
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.2. Esomeprazole IV 40 mg - 5d QD (Hassan-Alin2000, Wilder-Smith2005)",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Hassan-Alin2000.Esomeprazole.40mg.IV_30min_infusion",
                                    "Wilder-Smith2005.Esomeprazole.40mg.IV_30min_infusion_Day1",
                                    "Wilder-Smith2005.Esomeprazole.40mg.IV_30min_infusion_Day5"
                                ],
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.3. Esomeprazole IV 40mg(30min)+8mg/h - (Rohss2007)",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Rohss2007_Esomeprazole.40mg(30min)+8mg/h.IV_bolus+cnt_infusion",
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.4. Esomeprazole IV 80mg(30min)+4mg/h - SD (Rohss2007)",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Rohss2007_Esomeprazole.80mg(30min)+4mg/h.IV_bolus+cnt_infusion",
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.5. Esomeprazole IV 80mg(30min)+8mg/h - SD (Rohss2007) - pred",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Rohss2007_Esomeprazole.80mg(30min)+8mg/h.IV_bolus+cnt_infusion",
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.6. Esomeprazole IV 120mg(30min)+8mg/h - SD (Rohss2007)",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Rohss2007_Esomeprazole.120mg(30min)+8mg/h.IV_bolus+cnt_infusion",
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.7. Esomeprazole IV 120mg(2h)+8mg/h - SD (Rohss2007).",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Rohss2007_Esomeprazole.120mg(2h)+8mg/h.IV_bolus+cnt_infusion",
                                "Color": "#FF8000"
                            }
                        ]
                    },
                    {
                        "Caption": "Oral administration (model building)",
                        "Symbol": "TriangleOpen",
                        "OutputMappings": [
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.9 - Esomeprazole PO 40 mg oral solution- 5d QD (Hassan-Alin2005)",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hassan-Alin2005.Esomeprazole.40mg.po 1",
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.8 - Esomeprazole PO 20 mg oral solution- 5d QD (Hassan-Alin2005).",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hassan-Alin2005.Esomeprazole.20mg.po 1",
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.12 - SD in PM (no 2C19CL) - Esomeprazole PO 40 mg - FDA",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "FDA_Esomeprazole.40mg.po_PM",
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "Esomeprazole PO 40 mg capsule - 5d QD (Wilder-Smith2005)- with Fit formulation",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Wilder-Smith2005.Esomeprazole.40mg.po_Day1",
                                    "Wilder-Smith2005.Esomeprazole.40mg.po_Day5"
                                ],
                                "Color": "#FF8000"
                            }
                        ]
                    },
                    {
                        "Caption": "Oral administration (model validation)",
                        "Symbol": "Triangle",
                        "OutputMappings": [
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.9 - Esomeprazole PO 40 mg oral solution- 5d QD (Hassan-Alin2005)",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hassan-Alin2005.Esomeprazole.40mg.po 1",
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.8 - Esomeprazole PO 20 mg oral solution- 5d QD (Hassan-Alin2005).",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hassan-Alin2005.Esomeprazole.20mg.po 1",
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.12 - SD in PM (no 2C19CL) - Esomeprazole PO 40 mg - FDA",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "FDA_Esomeprazole.40mg.po_PM",
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.11 - SD in EM - Esomeprazole PO 40 mg- FDA - same schema as E.9",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "FDA_Esomeprazole.40mg.po_EM",
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.13 - MD in EM - Esomeprazole PO 15 mg solution (Andersson2000)",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Andersson2000.Esomeprazole.15mg.po.EM",
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "E.14 - MD in PM (no 2C19CL) - Esomeprazole PO 60 mg solution (Andersson2000)",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Andersson2000.Esomeprazole.60mg.po.PM",
                                "Color": "#00ffbf"
                            }
                        ]
                    }
                ]
            },
            {
                "Title": "R-omeprazole concentration in plasma - mean data",
                "SectionReference": "diagnostics-plots",
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure"
                ],
                "PlotTypes": [
                    "predictedVsObserved",
                    "residualsOverTime"
                ],
                "Groups": [
                    {
                        "Caption": "Oral administration (model building)",
                        "Symbol": "Triangle",
                        "OutputMappings": [
                            {
                                "Project": "Omeprazole",
                                "Simulation": "R.3 - R-omeprazole po 15 mg - 7d QD (Andersson2000) - EM",
                                "Output": "Organism|PeripheralVenousBlood|R-omeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Andersson2000 from Andersson2001-.R-omeprazole.15.po.EM",
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "R.1 - R-omeprazole po 20 mg - 5d QD (Hassan-Alin2005)",
                                "Output": "Organism|PeripheralVenousBlood|R-omeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Hassan-Alin2005 from Wu2014 - R-omeprazole.20mg.po",
                                    "Hassan-Alin2005 from Wu2014 - R-omeprazole.20mg.po.Day5",
                                    "Hassan-Alin2005.R-omeprazole.20mg.po"
                                ],
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "R.2 - R-omeprazole po 40 mg - 5d QD (Hassan-Alin2005)",
                                "Output": "Organism|PeripheralVenousBlood|R-omeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hassan-Alin2005.R-omeprazole.40mg.po",
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "R.4 - R-omeprazole po 60 mg - 7d QD (Andersson2000) - PM - CL Fit",
                                "Output": "Organism|PeripheralVenousBlood|R-omeprazole|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Andersson2000 from Andersson2001-.R-omeprazole.60.po.PM",
                                "Color": "#FF8000"
                            }
                        ]
                    }
                ]
            },
            {
                "Title": "Omeprazole concentration in plasma - mean data",
                "SectionReference": "diagnostics-plots",
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure"
                ],
                "PlotTypes": [
                    "predictedVsObserved",
                    "residualsOverTime"
                ],
                "Groups": [
                    {
                        "Caption": "Oral administration (model validation)",
                        "Symbol": "Triangle",
                        "OutputMappings": [
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O8. Omeprazole po 20 mg - oral solution - SD and MD",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Hassan-Alin2005.Omeprazole.20mg.po",
                                    "Regardh1990.Omeprazole.20mg.po_7",
                                    "Regardh1990.Omeprazole.20mg.po_Median"
                                ],
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O8. Omeprazole po 20 mg - 5d QD - capsule",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Andersson1998.Omeprazole.20mg.po_EM",
                                    "Andersson1991.Omeprazole.20mg.po_Day1",
                                    "Andersson1991.Omeprazole.20mg.po_Day5"
                                ],
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O7. Omeprazole po 40mg - oral solution- SD and MD",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Hassan-Alin2005.Omeprazole.40mg.po",
                                    "Andersson1990.Omeprazole.40mg.po",
                                    "Andersson1991.Omeprazole.40mg.po_Day1",
                                    "Andersson1991.Omeprazole.40mg.po_Day5"
                                ],
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O9. Omeprazole po 15 mg - oral solution - (Andersson2000) - MD in EM",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Andersson2000 from Andersson2001-.Omeprazole.15.po.EM",
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O91. Omeprazole po 80 mg - oral solution - SD",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Andersson1990.Omeprazole.80mg.po",
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O7. Omeprazole po 40 mg - 5d QD japanese - capsule - EM",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Uno2007.Omeprazole.40mg.po_hmEM",
                                    "Uno2007.Omeprazole.40mg.po_htEM"
                                ],
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O8. Omeprazole po 20 mg - 5d QD - capsule - PM",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Andersson1998.Omeprazole.20mg.po_PM",
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O.9. Omeprazole DDI without fluvoxamine",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Yasui-Furukori2004.omeprazole.40mg.po.japanese hmEM 1",
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O.1. pop - Omeprazole po 20 mg - DDI without moclobemide - (Cho2002)",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Cho2002.Mean Ompz.20mg.po.EM",
                                "Color": "#00ffbf"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O.1. pop - Omeprazole po 20 mg - DDI without moclobemide - (Cho2002)_pm",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Cho2002.Mean Ompz.20mg.po.PM",
                                    "Uno2007.Omeprazole.40mg.po_PM"
                                ],
                                "Color": "#00ffbf"
                            }
                        ]
                    },
                    {
                        "Caption": "Oral administration (model building)",
                        "Symbol": "TriangleOpen",
                        "OutputMappings": [
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O92. Omeprazole po 60 mg - oral solution - MD in PM",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Andersson2000 from Andersson2001-.Omeprazole.60.po.PM",
                                "Color": "#FF8000"
                            }
                        ]
                    },
                    {
                        "Caption": "iv administration (model building)",
                        "Symbol": "SquareOpen",
                        "OutputMappings": [
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O6. Omeprazole iv 80mg",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Andersson1990.Omeprazole.80mg.iv",
                                    "Oosterhuis1992.Omeprazole.80mg.IV_5min_infusion"
                                ],
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O1. Omeprazole iv 10 mg - SD (Regardh1990) - PM",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Regardh1990.Omeprazole.10mg.IV_5min_infusion_2",
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O2. Omeprazole iv 20 mg - SD in PM (Uno2007)",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Uno2007.Omeprazole.20mg.iv bolus_PM",
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O3. Omeprazole iv 40 mg - SD",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Oosterhuis1992.Omeprazole.40mg.IV_2.5min_infusion",
                                    "Andersson1990.Omeprazole.40mg.iv",
                                    "Andersson1991.Omeprazole.40mg.iv.Day1"
                                ],
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O4. Omeprazole iv 20 mg - SD",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Andersson1991.Omeprazole.20mg.iv.Day1",
                                    "Uno2007.Omeprazole.20mg.iv bolus_hmEM"
                                ],
                                "Color": "#FF8000"
                            },
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O5. Omeprazole iv 10mg",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Regardh1990.Omeprazole.10mg.IV_5min_infusion_7",
                                    "Regardh1990.Omeprazole.10mg.IV_5min_infusion_Median"
                                ],
                                "Color": "#FF8000"
                            }
                        ]
                    },
                    {
                        "Caption": "iv administration (model validation)",
                        "Symbol": "Square",
                        "OutputMappings": [
                            {
                                "Project": "Omeprazole",
                                "Simulation": "O5. Omeprazole iv 10mg",
                                "Output": "Organism|PeripheralVenousBlood|Esomeprazole|Omeprazole Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Andersson1991.Omeprazole.10mg.iv.Day1",
                                "Color": "#00ffbf"
                            }
                        ]
                    }
                ]
            }
        ],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [
        {
            "Project": "Omeprazole",
            "Name": "Esomeprazole",
            "Type": "Compound",
            "SectionReference": "final-input-parameters"
        },
        {
            "Project": "Omeprazole",
            "Name": "R-omeprazole",
            "Type": "Compound",
            "SectionReference": "final-input-parameters"
        },
        {
            "Project": "Omeprazole",
            "Name": "Omeprazole capsule",
            "Type": "Formulation",
            "SectionReference": "final-input-parameters"
        }
    ],
    "Sections": [
        {
            "Reference": "introduction",
            "Title": "Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Reference": "methods",
            "Title": "Methods",
            "Content": "Content/Section2_Methods.md",
            "Sections": [
                {
                    "Reference": "modeling-strategy",
                    "Title": "Modeling Strategy",
                    "Content": "Content/Section2.1_Modeling_Strategy.md"
                },
                {
                    "Reference": "data",
                    "Title": "Data",
                    "Content": "Content/Section2.2_Data.md"
                },
                {
                    "Reference": "model-parameters-and-assumptions",
                    "Title": "Model Parameters and Assumptions",
                    "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md"
                }
            ]
        },
        {
            "Reference": "results-and-discussion",
            "Title": "Results and Discussion",
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Sections": [
                {
                    "Reference": "final-input-parameters",
                    "Title": "Final input parameters",
                    "Content": "Content/Input_table.md"
                },
                {
                    "Reference": "diagnostics-plots",
                    "Title": "Diagnostics Plots",
                    "Content": "Content/GOF_diagnostics.md"
                },
                {
                    "Reference": "ct-profiles",
                    "Title": "Concentration-Time Profiles",
                    "Content": "Content/Concentration_time_profiles.md",
                    "Sections": [
                        {
                            "Reference": "model-building",
                            "Title": "Model Building",
                            "Content": "Content/Concentration_time_profiles_building.md"
                        },
                        {
                            "Reference": "model-verification",
                            "Title": "Model Verification",
                            "Content": "Content/Concentration_time_profiles_verification.md"
                        }
                    ]
                }
            ]
        },
        {
            "Reference": "conclusion",
            "Title": "Conclusion",
            "Content": "Content/Section4_Conclusion.md"
        },
        {
            "Reference": "references",
            "Title": "References",
            "Content": "Content/References.md"
        },
        {
            "Reference": "glossary",
            "Title": "Glossary",
            "Content": "Content/glossary.md"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}